A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing
Chandler-Brown, D.; Bueno, A. M.; Atay, O.; Tsao, D. S.
Show abstract
There is currently an urgent unmet need to increase coronavirus disease 2019 (COVID-19) testing capability to effectively respond to the COVID-19 pandemic. However, the current shortage in RNA extraction reagents as well as limitations in qPCR protocols have resulted in bottlenecks in testing capacity. Herein, we describe a novel molecular diagnostic for COVID-19 based on Sanger sequencing. This assay uses the addition of a frame-shifted spike-in, a modified PCR master mix, and custom Sanger sequencing data analysis to detect and quantify SARS-CoV-2 RNA at a limit of detection comparable to existing qPCR-based assays, at 10-20 genome copy equivalents. Crucially, our assay was able to detect SARS-CoV-2 RNA from viral particles suspended in transport media that was directly added to the PCR master mix, suggesting that RNA extraction can be skipped entirely without any degradation of test performance. Since Sanger sequencing instruments are widespread in clinical laboratories and commonly have built-in liquid handling automation to support up to 3840 samples per instrument per day, the widespread adoption of qSanger COVID-19 diagnostics can unlock more than 1,000,000 tests per day in the US.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection 96%
- A Fast and Accessible Method for the Isolation of RNA, DNA, and Protein to Facilitate the Detection of SARS-CoV-2 96%
- A Simple RT-PCR Melting temperature Assay to Rapidly Screen for Widely Circulating SARS-CoV-2 Variants 95%
Similar papers in this journal
- Multiplex Target-Redundant RT-LAMP for Robust Detection of SARS-CoV-2 Using Fluorescent Universal Displacement Probes 96%
- A Reagent and Virus Benchmarking Panel for a Uniform Analytical Performance Assessment of N Antigen–Based Diagnostic Tests for COVID-19 94%
- A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR 94%
Similar papers in this journal
Similar papers in this journal
- Development and Implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities 97%
- Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery 97%
- Deployable CRISPR-Cas13a diagnostic tools to detect and report Ebola and Lassa virus cases in real-time 94%
Similar papers in this journal
- A broad-based probe-free qPCR assay for detection and discrimination of three human herpes viruses 94%
- Comparison of Illumina MiSeq and the Ion Torrent PGM and S5 platforms for whole-genome sequencing of picornaviruses and caliciviruses 94%
- Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.